Beam Therapeutics

Beam Therapeutics

Biotechnology Research Cambridge, Massachusetts, United States 557 employees
Employees
557
Contacts
4
Emails
4
Phones
1

Beam Therapeutics Overview

Headquarters
Cambridge, Massachusetts, United States
Website
beamtx.com
Industry
Biotechnology Research
Employees
557
Founded
2017
Funding
500.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Beam Therapeutics

Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes. Our dream is to provide life-long cures for patients suffering from serious diseases. The Beam Team Is: • A community of fearless innovators • Rigorous and honest in our research • Listening with open minds • Committed to each other

Beam Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
1
25.0% coverage

Beam Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Jocelyn Mortero Executive Assistant
Email
Nada Martini
Email
William Schmidt Licensed Patent Attorney with Twenty
Email
Mandy Stone Sr. Director, Ehs at Beam Therapeutics
Email Phone

Employees by Management Level

Individual contributor 14 profiles
Director 11 profiles
Manager 5 profiles
Executive 2 profiles
Senior / Lead 2 profiles
Associate / junior 2 profiles

Department Contact Coverage

Department Contacts Email Phone
General 6 6 1
IT 5 5 2
Legal 3 3 2
Healthcare 1 1 1
Finance 1 1 0
Operations 1 1 0

Beam Therapeutics Tech Stack

Engineering 2 profiles
Cloud / infrastructure 1 profile
Data / AI 1 profile

Compare Similar Companies to Beam Therapeutics